Wim Ottevaere
Directeur/Bestuurslid bij SEQUANA MEDICAL N.V.
Oorsprong van het eerstegraads netwerk van Wim Ottevaere
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
38
| Subsidiary | Biotechnology | 38 |
| Public Company | Medical Specialties | 19 | |
14
| Public Company | Chemicals: Agricultural | 14 |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium.
12
| Subsidiary | Medical Specialties | 12 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Wim Ottevaere via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Katholieke Universiteit Leuven | College/University | Graduate Degree Doctorate Degree Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Doctorate Degree | |
Sequana Medical AG
 Sequana Medical AG Medical SpecialtiesHealth Technology Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland. | Medical Specialties | Director/Board Member Director/Board Member Chairman Chief Executive Officer Chief Tech/Sci/R&D Officer General Counsel | |
| University of Antwerp | College/University | Doctorate Degree Graduate Degree Graduate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
| Ghent University | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Founder Director of Finance/CFO Chairman General Counsel Director/Board Member | |
| University of Cambridge | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
| Université Catholique de Louvain | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree | |
| MORPHOSYS AG | Biotechnology | Chief Executive Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
MyCartis NV
 MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Chairman Chief Executive Officer Director/Board Member Chairman | |
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Vlerick Leuven Gent Management School | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| University of Utrecht | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
CropDesign NV
 CropDesign NV Miscellaneous Commercial ServicesCommercial Services CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| BIOCARTIS GROUP NV | Medical Specialties | Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Operating Officer | |
| EVOTEC SE | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Vlaams Instituut voor Biotechnologie - Flanders Institute
 Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | College/University | Director/Board Member Founder | |
JenaValve Technology, Inc.
 JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Medical Specialties | Director/Board Member Director/Board Member | |
Abingworth Management Ltd.
 Abingworth Management Ltd. Investment ManagersFinance Abingworth Management Ltd. operates as an investment firm with interests in the life sciences and healthcare sectors. It offers services for businesses in all stages of company development, including early and late-stage venture financing, growth equity, and public companies. The company was founded in 1973 and is headquartered in London, the United Kingdom. | Investment Managers | Director/Board Member Chairman | |
Confo Therapeutics NV
 Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| CELYAD ONCOLOGY SA | Biotechnology | Chairman Director/Board Member | |
| The University of Texas at Austin | College/University | Doctorate Degree Doctorate Degree | |
Antelope Dx BV
 Antelope Dx BV Packaged SoftwareTechnology Services Antelope Dx BV develops a point-of-need diagnostics platform that provides patients, consumers, and healthcare professionals with on-the-spot access to key health parameters. The private company is based in Ghent, Belgium. The Belgian company was founded in 2019 by Jan-Willem Hoste and Hilde Windels. Hilde Windels has been the CEO since 2019. | Packaged Software | Founder Director/Board Member | |
| GIMV NV | Investment Managers | Director/Board Member Corporate Officer/Principal | |
| PROQR THERAPEUTICS N.V. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Janssen Biotherapeutics | Corporate Officer/Principal Corporate Officer/Principal | ||
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Director/Board Member Private Equity Investor | |
| PHARMING GROUP N.V. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Pulsify Medical BV
 Pulsify Medical BV Medical SpecialtiesHealth Technology Pulsify Medical BV is a Belgian digital medical technology company that specializes in developing wearable ultrasound patches. The company is based in Louvain, Belgium. Pulsify Medical was founded in 2019 by Lieven Herbots, Xavier Rottenberg, Jan D'hooge, Steve Stoffels. Iwan van Vijfeijken has been the CEO of the company since 2019. | Medical Specialties | Director/Board Member Director/Board Member | |
| University of California, Berkeley | College/University | Undergraduate Degree Chief Tech/Sci/R&D Officer | |
| Philipps University of Marburg | College/University | Doctorate Degree Doctorate Degree | |
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Medical Specialties | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Graduate Degree | |
| AVANTIUM N.V. | Industrial Machinery | Chairman Director/Board Member | |
Evox Therapeutics Ltd.
 Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Chairman Chief Executive Officer | |
| The University of Sheffield | College/University | Doctorate Degree Undergraduate Degree | |
Ionix Pharmaceuticals Ltd.
 Ionix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ionix Pharmaceuticals Ltd. used to develop analgesic medicines for the treatment of acute and chronic pain. Its drugs were used for the treatment of pain associated with chronic debilitating diseases such as osteoarthritis, diabetes, cancer and multiple sclerosis. The company was founded by Andrew Sandham, Phillip J. Birch, John Wood and Ann Gail Hayes in 2001 and was located in Cambridge, UK. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Capricorn Partners NV
 Capricorn Partners NV Investment ManagersFinance Capricorn Partners NV (Capricorn) is an independent European licensed manager of private and public equity investment funds which was founded in 1993 as a joint venture between Dr Jos B. Peeters and Baring Venture Partners Ltd. In 1999, Capricorn became a fully partner-owned, independent firm. It is headquartered in Leuven, Belgium. | Investment Managers | Chairman Consultant / Advisor | |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal |
Statistieken
Internationaal
| België | 21 |
| Verenigd Koninkrijk | 12 |
| Verenigde Staten | 7 |
| Nederland | 6 |
| Duitsland | 4 |
Sectoraal
| Health Technology | 26 |
| Consumer Services | 16 |
| Finance | 5 |
| Commercial Services | 3 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 427 |
| Corporate Officer/Principal | 139 |
| Chairman | 133 |
| Independent Dir/Board Member | 96 |
| Chief Executive Officer | 62 |
Sterkste connecties
| Insiders | |
|---|---|
| Douglas Kohrs | 37 |
| Edwin Moses | 35 |
| Bo Jesper Hansen | 34 |
| Russell Greig | 31 |
| Catherine Moukheibir | 29 |
| Rudy Dekeyser | 29 |
| Denis Lucquin | 26 |
| John Berriman | 24 |
| Philippe Archinard | 24 |
| Mats Gunnar Pettersson | 23 |
| Erik Amble | 23 |
| Geert Cauwenbergh | 22 |
| Jim van Heusden | 22 |
| Remi Vermeiren | 22 |
| Stephen William Bunting | 22 |
- Beurs
- Insiders
- Wim Ottevaere
- Bedrijfsconnecties